Article
[Bone marrow failure and TP53 activating mutations].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2022
Ito Etsuro
Abstract excerpt
Inherited bone marrow failure syndrome (IBMFS) is a heterogeneous group of genetic disorders characterized by bone marrow failure, congenital anomalies, and an increased risk of malignancy. The p53 tumor suppressor protein is a transcription factor activated in response to various cellular stresses and induces genes involved in apoptosis, cell cycle arrest, and DNA repair. Several lines of evidence suggest that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
